Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1986;73:662-667

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winniford, M. D.
Right arrow Articles by Hillis, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winniford, M. D.
Right arrow Articles by Hillis, L. D.

Circulation, Vol 73, 662-667, Copyright © 1986 by American Heart Association


ARTICLES

Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone

MD Winniford, KR Wheelan, MS Kremers, V Ugolini, E van den Berg Jr, EH Niggemann, DE Jansen and LD Hillis

In patients with atherosclerotic coronary artery disease, cigarette smoking increases myocardial oxygen demand but may cause an inappropriate decrease in coronary blood flow and myocardial oxygen supply. This study was performed to explore the mechanism of smoking- induced coronary vasoconstriction and, specifically, to determine if smoking causes an alpha-adrenergically mediated increase in coronary artery tone. In 36 chronic smokers with coronary artery disease (27 men and nine women, 50 +/- 9 [mean +/- SD] years old), heart rate-systolic arterial pressure double product and coronary sinus blood flow (by thermodilution) were measured before and during smoking both before and after (1) normal saline (n = 5, control subjects), (2) an alpha- adrenergic-blocking agent, phentolamine, 5 mg (n = 15), (3) a beta- adrenergic-blocking agent, propranolol, 0.1 mg/kg (n = 12), or (4) sodium nitroprusside, 0.4 to 0.8 micrograms/kg/min, given in a dose sufficient to diminish systolic arterial pressure by 15% (n = 4). During the initial smoking period, rate-pressure product increased and coronary sinus blood flow was unchanged by smoking in all groups. After 30 to 75 min, saline, phentolamine, propranolol, or sodium nitroprusside was given, and measurements were repeated. In the control subjects, rate-pressure product and coronary sinus blood flow responded in a similar manner to that observed previously. In those receiving phentolamine, rate-pressure product was unchanged, but coronary sinus blood flow rose substantially with smoking (percent change +2 +/- 15% during the first smoking period [before phentolamine] and +32 +/- 17% during the second smoking period [after phentolamine]; p less than .01).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
ChestHome page
B. Lichodziejewska, K. Kurnicka, K. Grudzka, J. Malysz, M. Ciurzynski, and D. Liszewska-Pfejfer
Chronic and Acute Effects of Smoking on Left and Right Ventricular Relaxation in Young Healthy Smokers
Chest, April 1, 2007; 131(4): 1142 - 1148.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Najem, A. Houssiere, A. Pathak, C. Janssen, D. Lemogoum, O. Xhaet, N. Cuylits, and P. van de Borne
Acute Cardiovascular and Sympathetic Effects of Nicotine Replacement Therapy
Hypertension, June 1, 2006; 47(6): 1162 - 1167.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. Barbato, J. Bartunek, W. Aarnoudse, M. Vanderheyden, F. Staelens, W. Wijns, G. R. Heyndrickx, N. H.J. Pijls, and B. De Bruyne
Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses
Eur. Heart J., November 2, 2004; 25(22): 2034 - 2039.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Barbato, J. Bartunek, E. Wyffels, W. Wijns, G. R. Heyndrickx, and B. De Bruyne
Effects of intravenous dobutamineon coronary vasomotion in humans
J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1596 - 1601.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Neunteufl, S. Heher, K. Kostner, G. Mitulovic, S. Lehr, G. Khoschsorur, R. W. Schmid, G. Maurer, and T. Stefenelli
Contribution of nicotine to acute endothelial dysfunction in long-term smokers
J. Am. Coll. Cardiol., January 16, 2002; 39(2): 251 - 256.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. Hatada, T. Sugiura, H. Kamihata, S. Nakamura, N. Takahashi, F. Yuasa, and T. Iwasaka
Clinical Significance of Coronary Flow to the Infarct Zone Before Successful Primary Percutaneous Transluminal Coronary Angioplasty in Acute Myocardial Infarction
Chest, December 1, 2001; 120(6): 1959 - 1963.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. A. Lange and L. D. Hillis
Cardiovascular Complications of Cocaine Use
N. Engl. J. Med., August 2, 2001; 345(5): 351 - 358.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
L. Badimon, G. Vilahur, S. Sanchez, and X. Duran
Atheromatous plaque formation and thrombogenesis: formation, risk factors and therapeutic approaches
Eur. Heart J. Suppl., August 1, 2001; 3(suppl_I): I16 - I22.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T.-M. Lee, S.-F. Su, W.-Y. Suo, C.-Y. Lee, M.-F. Chen, Y.-T. Lee, and C.-H. Tsai
Distension of urinary bladder induces exaggerated coronary constriction in smokers with early atherosclerosis
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2838 - H2845.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Heusch, D. Baumgart, P. Camici, W. Chilian, L. Gregorini, O. Hess, C. Indolfi, and O. Rimoldi
{alpha}-Adrenergic Coronary Vasoconstriction and Myocardial Ischemia in Humans
Circulation, February 15, 2000; 101(6): 689 - 694.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. Giri, P. D. Thompson, F. J. Kiernan, J. Clive, D. B. Fram, J. F. Mitchel, J. A. Hirst, R. G. McKay, and D. D. Waters
Clinical and Angiographic Characteristics of Exertion-Related Acute Myocardial Infarction
JAMA, November 10, 1999; 282(18): 1731 - 1736.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. H. Markovitz, L. Tolbert, and S. E. Winders
Increased Serotonin Receptor Density and Platelet GPIIb/IIIa Activation Among Smokers
Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 762 - 766.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Minami, T. Ishimitsu, and H. Matsuoka
Effects of Smoking Cessation on Blood Pressure and Heart Rate Variability in Habitual Smokers
Hypertension, January 1, 1999; 33(1): 586 - 590.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. J. Jay and J. E. Hollander
Cocaine Use and Chest Pain Syndromes
Arch Intern Med, September 14, 1998; 158(16): 1827 - 1828.
[Full Text] [PDF]


Home page
CirculationHome page
K. Narkiewicz, P. J.H. van de Borne, M. Hausberg, R. L. Cooley, M. D. Winniford, D. E. Davison, and V. K. Somers
Cigarette Smoking Increases Sympathetic Outflow in Humans
Circulation, August 11, 1998; 98(6): 528 - 534.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Fukuda, M. Kitani, and H. Omodani
99mTc-HMPAO Brain SPECT Imaging in a Case of Repeated Syncopal Episodes Associated With Smoking
Stroke, July 1, 1997; 28(7): 1461 - 1463.
[Abstract] [Full Text]


Home page
CirculationHome page
C. Stefanadis, E. Tsiamis, C. Vlachopoulos, C. Stratos, K. Toutouzas, C. Pitsavos, S. Marakas, H. Boudoulas, and P. Toutouzas
Unfavorable Effect of Smoking on the Elastic Properties of the Human Aorta
Circulation, January 7, 1997; 95(1): 31 - 38.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Heitzer, S. Yla-Herttuala, J. Luoma, S. Kurz, T. Munzel, H. Just, M. Olschewski, and H. Drexler
Cigarette Smoking Potentiates Endothelial Dysfunction of Forearm Resistance Vessels in Patients With Hypercholesterolemia : Role of Oxidized LDL
Circulation, April 1, 1996; 93(7): 1346 - 1353.
[Abstract] [Full Text]


Home page
NEJMHome page
J. E. Hollander
The Management of Cocaine-Associated Myocardial Ischemia
N. Engl. J. Med., November 9, 1995; 333(19): 1267 - 1272.
[Full Text] [PDF]


Home page
CirculationHome page
E. Falk, P. K. Shah, and V. Fuster
Coronary Plaque Disruption
Circulation, August 1, 1995; 92(3): 657 - 671.
[Full Text]


Home page
ANN INTERN MEDHome page
A. D. Kugelmass and J. A. Ware
Cocaine and Coronary Artery Thrombosis
Ann Intern Med, May 1, 1992; 116(9): 776 - 777.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
R. L. Minor Jr., B. D. Scott, D. D. Brown, and M. D. Winniford
Cocaine-induced Myocardial Infarction in Patients with Normal Coronary Arteries
Ann Intern Med, November 15, 1991; 115(10): 797 - 806.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
R. A. Lange, R. G. Cigarroa, E. D. Flores, W. McBride, A. S. Kim, P. J. Wells, J. B. Bedotto, R. S. Danziger, and L. D. Hillis
Potentiation of Cocaine-Induced Coronary Vasoconstriction by Beta-Adrenergic Blockade
Ann Intern Med, June 15, 1990; 112(12): 897 - 903.
[Abstract] [PDF]


Home page
JAMAHome page
J. Barry, K. Mead, E. G. Nabel, M. B. Rocco, S. Campbell, T. Fenton, G. H. Mudge Jr, and A. P. Selwyn
Effect of Smoking on the Activity of Ischemic Heart Disease
JAMA, January 20, 1989; 261(3): 398 - 402.
[Abstract] [PDF]